Cogent Biosciences Inc’s recently made public that its 10% Owner Fairmount Funds Management LLC acquired Company’s shares for reported $9.6 million on Jun 09 ’23. In the deal valued at $12.00 per share,800,000 shares were bought. As a result of this transaction, Fairmount Funds Management LLC now holds 3,272,124 shares worth roughly $26.21 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Robert W. Baird downgraded its Cogent Biosciences Inc [COGT] rating to a Neutral from a an Outperform in a research note published on February 26, 2024; the price target was decreased to $8 from $14. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. Wedbush also remained covering COGT and has decreased its forecast on December 11, 2023 with a “Neutral” recommendation from previously “an Outperform” rating. JP Morgan started covering the stock on December 08, 2023. It rated COGT as “an Overweight”.
Price Performance Review of COGT
On Friday, Cogent Biosciences Inc [NASDAQ:COGT] saw its stock jump 9.88% to $8.01. Over the last five days, the stock has gained 6.94%. Cogent Biosciences Inc shares have risen nearly 36.22% since the year began. Nevertheless, the stocks have fallen -31.77% over the past one year. While a 52-week high of $13.50 was reached on 02/22/24, a 52-week low of $3.67 was recorded on 01/29/24. SMA at 50 days reached $7.05, while 200 days put it at $7.71. A total of 1.38 million shares were traded, compared to the trading of 1.67 million shares in the previous session.
Levels Of Support And Resistance For COGT Stock
The 24-hour chart illustrates a support level at 7.47, which if violated will result in even more drops to 6.94. On the upside, there is a resistance level at 8.36. A further resistance level may holdings at 8.72. The Relative Strength Index (RSI) on the 14-day chart is 55.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.14%. Stochastics %K at 44.63% indicates the stock is a holding.
The most recent change occurred on April 28, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $20 price target.
